MEDI+SIGN’s technology is a gateway to improving quality care by providing patients access to information on their caregivers and their treatment plans.
Smithsburg, Maryland (PRWEB)
June 20, 2017
MEDI+SIGN, a healthcare technology company that provides automated communication to the patient’s bedside, would like to officially welcome Anthony Stanowski, DHA, FACHE to the MEDI+SIGN Advisory Board.
“We are eager to work side-by-side with Dr. Stanowski whose insight and expertise in healthcare will provide invaluable direction for the company,” says Andrew Hoffman, President of MEDI+SIGN.
Dr. Stanowski is the President and CEO for the Commission on Accreditation of Healthcare Management Education (CAHME) which advances the quality of graduate healthcare management education through accreditation. He previously held executive and management positions at Fortune 200 companies, such as Aramark and Thomson Reuters Healthcare Division, academic and community based health systems, and small innovative entrepreneurial organizations.
On being named to the advisory board, Dr. Stanowski, a passionate champion of quality improvement and the patient experience, stated: “MEDI+SIGN’s technology is a gateway to improving quality care by providing patients access to information on their caregivers and their treatment plans. Expanding patient access to this technology can accelerate coordination of care and enhancing the patient experience.”
Dr. Stanowski is a frequent conference presenter, and co-authored the book, We Have a Match: My Journey through America’s Transplant System. He has extensive experience serving on healthcare boards; he currently chairs the Board Quality Committee at Bon Secours Baltimore Health…